Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17257247 | STRUCTURE | December 2020 | May 2024 | Abandon | 41 | 0 | 1 | No | No |
| 17132284 | SYSTEMS AND METHODS RELATED TO COLLECTION OF BIOLOGICAL FLUIDS | December 2020 | August 2023 | Allow | 31 | 0 | 1 | No | No |
| 17253050 | BLOOD CLEANSING SYSTEM | December 2020 | January 2024 | Abandon | 37 | 1 | 0 | No | No |
| 17251552 | MEDICATION INFUSION DEVICES, SYSTEMS, AND METHODS | December 2020 | March 2024 | Allow | 39 | 2 | 0 | No | No |
| 17058569 | IMPROVEMENTS IN OSTOMY ATTACHMENTS | November 2020 | June 2024 | Allow | 43 | 5 | 0 | Yes | No |
| 17097512 | PHYSIOLOGICAL PANTS | November 2020 | June 2024 | Allow | 43 | 1 | 0 | No | No |
| 17095844 | PLUG FOR INSERTION INTO THE NOSE OR EAR OF A SUBJECT AND METHOD FOR ADMINISTERING A FLUID THERAPEUTIC AGENT USING SAID PLUG | November 2020 | January 2025 | Allow | 50 | 2 | 1 | No | No |
| 17083575 | FELINE FOLEY CATHETER | October 2020 | December 2023 | Abandon | 37 | 2 | 0 | Yes | No |
| 17081028 | Vaginal Cleansing Device | October 2020 | December 2023 | Abandon | 38 | 1 | 0 | No | No |
| 17046411 | ANCHORING DEVICES FOR IMPLANTED TUBES AND RELATED METHODS | October 2020 | May 2024 | Allow | 43 | 1 | 0 | No | No |
| 17045956 | METHOD TO DYNAMICALLY MEASURE APPOSITION AND PATIENT LIMB MOVEMENT IN A NEGATIVE PRESSURE CLOSED INCISION DRESSING | October 2020 | November 2023 | Allow | 37 | 4 | 1 | No | No |
| 17062589 | NASAL PLUG | October 2020 | December 2024 | Allow | 51 | 2 | 0 | No | No |
| 16976146 | DEVICE FOR MONITORING THE VASCULAR ACCESS IN AN EXTRACORPOREAL BLOOD TREATMENT | August 2020 | February 2023 | Allow | 30 | 3 | 0 | Yes | No |
| 16970967 | SENSOR ASSEMBLY PART AND A BASE PLATE FOR A MEDICAL APPLIANCE AND A DEVICE FOR CONNECTING TO A BASE PLATE AND/OR A SENSOR ASSEMBLY PART | August 2020 | November 2023 | Allow | 39 | 4 | 0 | No | No |
| 16984490 | SURGICAL CLEANING TOOL, SYSTEMS, AND METHODS | August 2020 | June 2023 | Allow | 34 | 2 | 0 | No | No |
| 16961768 | SYSTEMS AND METHODS FOR SENSING PROPERTIES OF WOUND EXUDATES | July 2020 | January 2024 | Allow | 42 | 4 | 0 | Yes | Yes |
| 16921084 | SYSTEMS INCLUDING EXTERNAL CATHETER FOR AUTOMATICALLY COLLECTING URINE FROM A FEMALE PATIENT AND METHODS OF USE | July 2020 | March 2023 | Abandon | 32 | 2 | 0 | No | No |
| 15733338 | DEVICE TO BE DEPLOYED AND RETAINED IN TWO OPPOSITE CAVITIES | July 2020 | August 2023 | Allow | 37 | 2 | 0 | Yes | No |
| 16901578 | BLADDER IRRIGATION TOOL | June 2020 | November 2024 | Abandon | 53 | 4 | 0 | Yes | Yes |
| 16888292 | Medical Suction Devices and Uses Thereof | May 2020 | May 2025 | Allow | 59 | 6 | 0 | Yes | No |
| 16864275 | CALCULATING CARDIAC OUTPUT OF A PATIENT UNDERGOING VENO-VENOUS EXTRACORPOREAL BLOOD OXYGENATION | May 2020 | January 2023 | Allow | 32 | 2 | 1 | Yes | No |
| 16858233 | CATHETER INCLUDING ONE OR MORE SENSORS | April 2020 | May 2023 | Abandon | 37 | 1 | 0 | No | No |
| 16856386 | Control System | April 2020 | July 2024 | Allow | 51 | 3 | 1 | Yes | No |
| 16836721 | BLOOD MONITORING SYSTEM FOR DETERMINING A CALIBRATED HEMOGLOBIN CONCENTRATION VALUE FOR A PATIENT BASED ON PATIENT-SPECIFIC MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION DATA | March 2020 | August 2023 | Abandon | 40 | 2 | 0 | No | No |
| 16834079 | METHOD FOR AUTOMATICALLY REMOVING URINE FROM A FEMALE PATIENT | March 2020 | November 2022 | Abandon | 31 | 2 | 0 | No | No |
| 16783222 | Stoma Cleaning Apparatus and Method | February 2020 | August 2023 | Abandon | 42 | 4 | 1 | Yes | No |
| 16781035 | MEDICAL DEVICE DISLODGMENT DETECTION | February 2020 | May 2023 | Abandon | 39 | 2 | 0 | Yes | No |
| 16635638 | APPARATUSES AND METHODS FOR REMOVING FLUID FROM A WOUND UTILIZING CONTROLLED AIRFLOW | January 2020 | August 2023 | Abandon | 42 | 3 | 0 | No | No |
| 16748376 | MEDICAL ASPIRATION | January 2020 | March 2025 | Allow | 60 | 6 | 1 | Yes | Yes |
| 16631686 | DRUG MIXING DEVICE | January 2020 | October 2022 | Abandon | 33 | 1 | 0 | No | No |
| 16729160 | DIAPER STATE SENSOR AND NOTIFICATION NETWORK | December 2019 | May 2023 | Abandon | 41 | 1 | 0 | No | No |
| 16622331 | METHOD AND APPARATUS FOR ADDING AN ANTICOAGULANT TO THE BLOOD OF A PATIENT | December 2019 | October 2022 | Allow | 34 | 2 | 0 | Yes | No |
| 16710977 | Method and Apparatus for a Perforable Absorbent Portion Bandage (PAP-B) for Avoidance of Constant Adhesive Removal | December 2019 | November 2022 | Abandon | 36 | 2 | 0 | Yes | No |
| 16707788 | CANNULAS AND CANNULA ASSEMBLIES FOR HEMODIALYSIS | December 2019 | March 2023 | Abandon | 39 | 1 | 1 | No | No |
| 16620677 | HOLDER FOR A CURVED DUCT PORTION | December 2019 | November 2022 | Allow | 35 | 2 | 0 | Yes | Yes |
| 16685982 | ASPIRATION STENOSIS AND METHOD THEREFOR | November 2019 | April 2024 | Abandon | 53 | 4 | 0 | No | No |
| 16613768 | NEGATIVE PRESSURE WOUND THERAPY SYSTEM USING EULERIAN VIDEO MAGNIFICATION | November 2019 | February 2024 | Allow | 51 | 5 | 0 | Yes | No |
| 16613350 | SKIN BARRIER INCLUDING SKIN FRIENDLY INGREDIENTS | November 2019 | December 2024 | Allow | 60 | 6 | 1 | Yes | Yes |
| 16612922 | ABSORBENT ARTICLE | November 2019 | May 2023 | Abandon | 42 | 4 | 0 | Yes | No |
| 16610568 | ABSORBENT BIOPHOTONIC DEVICES AND SYSTEMS FOR WOUND HEALING | November 2019 | May 2023 | Abandon | 42 | 3 | 0 | No | No |
| 16602519 | Wound Dressing containing a vacuum pump | October 2019 | January 2024 | Abandon | 50 | 4 | 0 | Yes | No |
| 16498412 | BODY SIDE MEMBER OF AN OSTOMY APPLIANCE | September 2019 | November 2023 | Allow | 50 | 6 | 0 | Yes | No |
| 16498597 | Flow Sensor for Cerebral Fluidic Device | September 2019 | August 2023 | Allow | 46 | 4 | 0 | Yes | No |
| 16490819 | ULTRASONIC THROMBUS REMOVING SYSTEM | September 2019 | October 2022 | Allow | 37 | 1 | 0 | Yes | No |
| 16520259 | DISPOSABLE COMPOSTABLE DIAPER AND FULFILLMENT SERVICE | July 2019 | July 2023 | Abandon | 47 | 1 | 1 | No | No |
| 16479938 | DEVICE AND METHOD FOR AUTOMATICALLY VENTING AND FILLING A CATHETER | July 2019 | May 2024 | Abandon | 58 | 2 | 0 | No | No |
| 16422929 | Hydrotherapy Device | May 2019 | October 2022 | Allow | 41 | 2 | 1 | No | No |
| 16331487 | TYMPANOSTOMY TUBE AND PLACEMENT DEVICE | March 2019 | September 2022 | Allow | 43 | 2 | 0 | Yes | No |
| 16327450 | Tool(s) for Inserting a Glaucoma Shunt | February 2019 | January 2023 | Allow | 47 | 3 | 0 | Yes | No |
| 16302280 | AFTER-INSECT BITE DEVICE AND METHOD | November 2018 | October 2022 | Abandon | 47 | 1 | 0 | No | No |
| 16089453 | WOUND THERAPY SYSTEM | September 2018 | April 2023 | Abandon | 54 | 2 | 0 | No | No |
| 16066211 | LOW PARTICULATE SURGICAL SPEAR | June 2018 | November 2022 | Abandon | 52 | 0 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner O'CONNELL, RACHEL.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner O'CONNELL, RACHEL works in Art Unit 3781 and has examined 52 patent applications in our dataset. With an allowance rate of 51.9%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 42 months.
Examiner O'CONNELL, RACHEL's allowance rate of 51.9% places them in the 15% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by O'CONNELL, RACHEL receive 2.54 office actions before reaching final disposition. This places the examiner in the 71% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by O'CONNELL, RACHEL is 42 months. This places the examiner in the 20% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +35.1% benefit to allowance rate for applications examined by O'CONNELL, RACHEL. This interview benefit is in the 82% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 19.0% of applications are subsequently allowed. This success rate is in the 21% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 30.0% of cases where such amendments are filed. This entry rate is in the 45% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 50.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 47% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 99% percentile among all examiners. Of these withdrawals, 40.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 7% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 45% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.